Clinical efficacy of components medicine of Zuojin Pills in the treatment of chronic non-atrophic gastritis: a randomized, parallel trial
- Conditions
- chronic non-atrophic gastritis
- Registration Number
- ITMCTR2000004125
- Lead Sponsor
- The Fifth Medical Center of Chinese PLA General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. Comply with the Consensus Opinions on Chronic Gastritis in China (2017, Shanghai) diagnostic criteria for chronic non-atrophic gastritis and Principles for Clinical Research of New Chinese Medicines for stagnant heat syndrome of liver and stomach;
2. Aged 18 to 65 years old;
3. The subjects signed an informed consent form.
1. Patients with severe dysplasia of gastric mucosa and suspected malignant transformation in pathological diagnosis;
2. Exclude patients with autoimmune gastritis through serum gastrin, vitamin B12 levels and related autoantibodies (anti-parietal cell antibodies and anti-intrinsic factor antibodies);
3. People with severe primary diseases of the heart and brain system;
4. Women who are pregnant, breastfeeding or planning to become pregnant in the near future;
5. Those who are allergic to the drugs used in this study or their components;
6. People with mental illness or unable to cooperate.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Gastroscopy score;
- Secondary Outcome Measures
Name Time Method TCM Syndrome Points;Clinical efficacy;safety;